Alzheimer’s disease drug, lecanemab

Alzheimer’s disease drug, lecanemab image

Home » News » Alzheimer’s disease drug, lecanemab

An NHS spokesperson said:

“The NHS now awaits a final decision from the National Institute for Health and Care Excellence that will look at the clinical benefits and cost-effectiveness of lecanemab and determine if it should be routinely offered by the NHS in England.

“Lecanemab is the first disease modifying treatment for Alzheimer’s disease with a market approval in the UK, and to ensure the health system is prepared for future advances in treatments, a dedicated NHS team is also looking ahead to 27 other drugs which are currently in advanced clinical trials that could be potentially approved by 2030.”

View all news

Latest news and highlights

Case Study

27 October 2025

Innovative facial analysis app recognises pain in care home residents

Danecroft is a 34-bed care home in Bedford, predominantly caring for people living with dementia but also other conditions such as Parkinson’s and MS. Since…

News

24 October 2025

Half term clinics to offer catch-up vaccinations for children

Parents of children who are behind on any of their immunisations have been reminded that there will be an opportunity to catch up on any…

News

17 October 2025

Local care providers use digital toolkit to monitor vital signs and prevent…

A remote monitoring toolkit has demonstrated potential for empowering care staff to make data-led healthcare decisions about the people they care for. The Whzan blue box measures vital signs such…

News

15 October 2025

One in five eligible people has already had their flu jab

One in five people eligible for the flu immunisation in Bedfordshire, Luton and Milton Keynes has already had their vaccination, new figures show. It’s always a good idea to get…

Case Study

9 October 2025

Robotic pets comfort Bedford care home residents with dementia

Bedford-based care home residents are reaping the benefits of robotic therapy pets. Hepworth House Residential Care Home has 15 residents and since April 2025, two residents with dementia have been…

News

2 October 2025

Digital tool improves mobility and balance in people at risk of falls

The largest real-world evaluation of GaitSmart, an AI-driven digital tool for people with gait (walking pattern) and mobility issues across four sites in Bedfordshire, Luton and Milton Keynes, has seen improved health…